INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 36 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $144,566 | +35.3% | 146,000 | +33.9% | 0.00% | – |
| Q4 2022 | $106,823 | +1.7% | 109,000 | 0.0% | 0.00% | – |
| Q3 2022 | $105,000 | +72.1% | 109,000 | +70.3% | 0.00% | – |
| Q2 2022 | $61,000 | +32.6% | 64,000 | +28.0% | 0.00% | – |
| Q1 2022 | $46,000 | -2.1% | 50,000 | 0.0% | 0.00% | – |
| Q4 2021 | $47,000 | +4.4% | 50,000 | 0.0% | 0.00% | – |
| Q3 2021 | $45,000 | -50.0% | 50,000 | -50.0% | 0.00% | – |
| Q2 2021 | $90,000 | +11.1% | 100,000 | 0.0% | 0.00% | – |
| Q1 2021 | $81,000 | +44.6% | 100,000 | +38.9% | 0.00% | – |
| Q4 2020 | $56,000 | -59.1% | 72,000 | -57.6% | 0.00% | – |
| Q3 2020 | $137,000 | -9.3% | 170,000 | -15.0% | 0.00% | – |
| Q2 2020 | $151,000 | -32.6% | 200,000 | -28.6% | 0.00% | -100.0% |
| Q1 2020 | $224,000 | -20.6% | 280,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $282,000 | -11.3% | 280,000 | -24.3% | 0.00% | 0.0% |
| Q3 2019 | $318,000 | -3.6% | 370,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $330,000 | -9.8% | 370,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $366,000 | +18.4% | 370,000 | +10.4% | 0.00% | 0.0% |
| Q4 2018 | $309,000 | -8.8% | 335,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $339,000 | – | 335,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 12,851,000 | $12,016,000 | 2.95% |
| Context Capital Management, LLC | 3,000,000 | $2,804,000 | 2.24% |
| Man Investments (CH) AG | 3,000,000 | $2,798,000 | 1.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,500,000 | $39,540,000 | 1.52% |
| MACKAY SHIELDS LLC | 17,069,000 | $15,982,000 | 0.73% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 73,035,000 | $68,425,000 | 0.63% |
| WOLVERINE ASSET MANAGEMENT LLC | 42,307,000 | $39,554,000 | 0.61% |
| LINDEN ADVISORS LP | 14,122,000 | $13,194,000 | 0.49% |
| GLG LLC | 9,100,000 | $8,486,000 | 0.47% |
| Jabre Capital Partners S.A. | 3,400,000 | $3,179,000 | 0.38% |